AzTrials
AzTrials

Congenital Lung MalformationsMALFPULM2NCT06424392

Respiratory and Psychological Impact of Elective Surgery of Congenital Lung Malformations

An observational study of Congenital Lung Malformations, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The absence of surgery of Congenital lung malformations (CLMs), if it avoids a stressfull event, is accompanied by a "medicalization" of the child, which will be regularly followed up in a specialized medical and surgical environment. Read more about this study

Who is it for?
Ages 6 to 9 years
Conditions the study is for
Congenital Lung Malformations
What is being tested?
General Health Questionnaire (GHQ-12), State-Trait Anxiety Inventory (STAI-Y) and Revised Children's Manifest Anxiety Scale (RCMAS)
How many people
434 participants
Where
1 siteFrance
Study dates
19 Dec 2024to Jun 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 9 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: The families of all children included in MALFPULM who have had at least one follow-up visit between 0 and 2 years of age.

Who may be able to join

  • Child of the MALFPULM cohort, with their parents
  • At least one follow-up visit between 0 and 2 years of age (n= 414 eligible children)
  • Non-opposition of the family

Who cannot join

  • Child with CLM, but not included in MALFPULM
  • Parents who participated in MALPULM, but with prenatal fetal death, or neonatal death.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Christophe DELACOURT, MD, PhD contact

+33 144494838

christophe.delacourt@aphp.fr

France1 site, 1 recruiting
  • Hôpital Necker Enfants Malades

    Paris, 75015

    Christophe DELACOURT, MD, PhD, 01 44 49 48 38, christophe.delacourt@aphp.fr

    Recruiting

Other trials in France

About this study

The absence of surgery of Congenital lung malformations (CLMs), if it avoids a stressfull event, is accompanied by a "medicalization" of the child, which will be regularly followed up in a specialized medical and surgical environment. The persistent risk of complication, albeit low, is likely to induce over-protective parental behaviours, and to be associated with a sustained family anxiety reaction. The main objective is to test the hypothesis that the absence of surgery has a significant impact on parental anxiety, measurable at 6- 9 years of age.

Read the detailed description

The knowledge of CLMs has been revolutionized by prenatal imaging and the identification of large numbers of CLMs that remain asymptomatic. France is a leader in this field, having set up the only prospective multicentre cohort currently available internationally, with follow-up starting in the prenatal period (MALFPULM). This cohort has already enabled a better description of the prenatal history and the development of an algorithm predictive of the risk of neonatal respiratory distress. The children were followed up to the age of 2 years, and 66% of them were operated on between 0 and 2 years of age. This cohort is a unique opportunity to measure the mid-term impact of this surgical decision, in terms of both medical complications and psychological consequences.

In particular, the size of the cohort makes it possible to answer with a sufficient level of evidence to the following controversies:

  • What is the risk of CLM infection in the absence of surgical removal, and is this risk dependent on the CLM phenotype?
  • What is the functional respiratory impact of surgical techniques (thoracoscopy or thoracotomy), depending on the age of the surgery?
  • What is the prevalence of musculoskeletal complications according to surgical techniques (thoracoscopy or thoracotomy)?
  • What is the burden of the medical or surgical follow-up depending on the chosen therapeutic option?
  • What is the psychological impact of the surgical decision on the parents and the child? Considering the psychological impact is a major issue for this malformative condition which mainly concerns asymptomatic children, and is of great originality because it has never been evaluated. The most recent literature clearly calls for integrating issues of family well-being and parental mental health into the follow-up of children with chronic disease and/or congenital anomalies. For this reason, the investigators chose maternal anxiety as the main criterion of this study. Specifically for CLM, demonstrating the impact of the investigator's decisions on the psychological state of the parents will be a strong encouragement to integrate this dimension in care, for a better detection of these anxious and/or depressive parental reactions, and a better personalization of the transmission of decisions.
Being tested
General Health Questionnaire (GHQ-12), State-Trait Anxiety Inventory (STAI-Y), Revised Children's Manifest Anxiety Scale (RCMAS), World Health Organization Quality of Life (WHOQOL-BREF), Parental Educational Competence Self-Evaluation Questionnaire "Questionnaire d'Auto-Évaluation de la Compétence Éducative Parentale (QAECEP)"
Keywords
Congenital lung malformations, Psychological impact

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • General Health Questionnaire (GHQ-12)Other

    Anxiety and depression self-reported scales for both parents

  • State-Trait Anxiety Inventory (STAI-Y)Other

    Anxiety and depression self-reported scales for both parents

  • Revised Children's Manifest Anxiety Scale (RCMAS)Other

    Anxiety and depression self-reported scales for children

  • World Health Organization Quality of Life (WHOQOL-BREF)Other

    Quality of life self-reported scales for parents

  • Parental Educational Competence Self-Evaluation Questionnaire "Questionnaire d'Auto-Évaluation de la Compétence Éducative Parentale (QAECEP)"Other

    Parental Educational Competence Self-Evaluation self-reported Questionnaire for parents

  • Parental interviewOther

    The interview will only last about ten minutes and will take place during the first call, if the parents have agreed and are sufficiently available to answer. If the parents are not available, an appointment can be made at a later date

Study groups in NCT06424392
Study groupRoleWhat they receive
6-9 years children with their parent(s)with fetal diagnoses of CLM6-9 years children with their parent(s) with fetal diagnoses of CLM and included in MALFPULM who have had at least one follow-up visit between 0 and 2 years of age.
Receives: Other: General Health Questionnaire (GHQ-12); Other: State-Trait Anxiety Inventory (STAI-Y); Other: Revised Children's Manifest Anxiety Scale (RCMAS); Other: World Health Organization Quality of Life (WHOQOL-BREF); Other: Parental Educational Competence Self-Evaluation Questionnaire "Questionnaire d'Auto-Évaluation de la Compétence Éducative Parentale (QAECEP)"; Other: Parental interview

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. maternal anxiety level

    The level of maternal anxiety is measured using the GHQ-12 anxiety scale. The GHQ ( General Health Questionnaire) consists of 12 items, each assessing the severity of a mental problem over the past few weeks. Each reponse is scored from 0 to 3, with a total score ranging from 0 to 36. Higher scores indicate poorer health.

    Measured: 1 year

Secondary outcomes (13)
  1. Impact of the surgical decision on respiratory morbidity - lower respiratory tract infections

    Number of lower respiratory tract infections, either documented (radiological opacity) or not, in the last 12 months and from birth to the date of evaluation

    Measured: 1 year

  2. Impact of the surgical decision on respiratory morbidity - hospitalizations

    Number of hospitalizations for respiratory reasons in the last 12 months and from birth to the date of evaluation

    Measured: 1 year

  3. Impact of the surgical decision on respiratory morbidity - severe wheezing respiratory exacerbations

    Number of severe wheezing respiratory exacerbations in the last 12 months, defined as requiring oral corticosteroids, emergency visit and/or hospitalization

    Measured: 1 year

  4. Impact of the surgical decision on respiratory morbidity - treatment

    Current regular treatment for respiratory purposes, defined as daily treatment for at least 3 consecutive months in the last 12 months

    Measured: 1 year

  5. Impact of the surgical decision on respiratory morbidity - lung function tests

    Following parameters will be collected: date of performance, weight and height at date of performance, total lung capacity (TLC), forced vital capacity (FVC), forced expiratory volume in one second (FEV1), Forced expiratory flow at 25-75% (FEF25-75%), transfer factor of the lung for carbon monoxide (TLCO). FVC, FEV1, and FEF25-75%. These measurements will allow to identify following functional profiles:

    • lung function restriction, defined by TLC lower than -1.645 Z score
    • airway obstruction, defined by FEV1/FVC lower than -1.645 Z score, and its reversibility, defined by an improvement of at least 12% of the FV1 after inhalation of salbutamol.
    • impaired diffusion capacity, defined by DLCO lower than -1.645 Z score.

    Measured: 1 year

  6. Impact of the surgical decision on respiratory morbidity - thoracic deformities

    The parents's declare rate of thoracic deformities

    Measured: 1 year

  7. Impact of the surgical decision on respiratory morbidity - burden of the medical or surgical follow-up

    The burden of the medical or surgical follow-up will be evaluated by the number of specialist consultations and the number of CT or MRI scans

    Measured: 1 year

  8. Anxiety and depression - GHQ-12

    The 12-item GHQ (General Health Questionnaire) was designed to be a self-administered screening test aimed at detecting minor psychiatric disorders and had been and validated in different languages, including French. It allows to estimate the prevalence of psychological distress in a given population (34). The GHQ-12 consists of 12 items, each one assessing the severity of a mental problem over the past few weeks, with four response options, and using six positively phrased and six negatively phrased. It takes less than 5 minutes to complete. It is scored from 0 to 3 for each response with a total possible score on the ranging from 0 to 36. High scores indicate worse health.

    Measured: 1 year

  9. Anxiety and depression - STAI-Y

    The State-Trait Anxiety Inventory (STAI-Y) is a 20-item self-measure of state anxiety level in parents, complementary of GHQ-28. It reflects the current subjective feeling of tension, apprehension, nervousness, and worry and is widely used both in practice and in clinical research.

    Measured: 1 year

  10. Anxiety and depression - RCMAS

    The RCMAS is a 37-item, self-report instrument designed to assess the level and nature of anxiety. A Total Anxiety score is computed based on 28 items, which are divided into three anxiety subscales: physiological anxiety (10 items about somatic manifestations of anxiety such as sleep difficulties, nausea and fatigue), worry/oversensitivity (11 items measuring obsessive concerns about a variety of things, most of which are typically vague and ill-defined, as well as fears about being hurt or emotionally isolated), and social concerns/concentration (7 items measuring distracting thoughts and fears that have a social or interpersonal nature). The remaining nine items on the RCMAS constitute the Lie subscale. A high score indicates a high level of anxiety or lie on that subscale.

    Measured: 1 year

  11. Quality of life - WHOQOL-BREF

    The WHOQOL-BREF is an abbreviated form of the WHOQOL-100 with only 26 items. It is an instrument for recording subjective quality of life. This is defined as an individual perception of one's own life situation in the context of culture and value system as well as personal goals, expectations, evaluation criteria and interests. It is a self-questionnaire that includes the four domains "physical health", "psychological well-being", "social relationships" and "environment". The items are answered using a five-level scale. The scales have a very high internal consistency. It is validated in several languages, including French.

    Measured: 1 year

  12. Parenting Sense of Competence questionnaire

    This questionnaire evaluates the parent's sense of competence in his or her role as an educator and has two components: the "skill/knowledge" factor, which evaluates the respondents' perception of the skills and knowledge they have acquired in order to be adequate parents (8 items); the "value/ease" factor, which evaluates the value that the respondent places on the role of parent, as well as his or her ease in this role (9 items).

    Measured: 1 year

  13. Over-protective parental behaviours

    The over-protective parental behaviours is defined by the age of attendance in first community (5 or more children), the care arrangements between 0 and 2 years, the after-school activities in the previous year and the travel outside France in the last two years

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2024
  2. Study start19 Dec 2024
  3. Primary completionJun 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
434 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06424392
Sponsor's protocol ID
2024-A00576-41
Acronym
MALFPULM2
Status last verified
Mar 2026
First submitted
16 May 2024
Last updated
23 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Congenital Lung Malformations, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christophe DELACOURT, MD, PhD (+33 144494838, christophe.delacourt@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

maternal anxiety level (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in